There should soon be several articles in the mainstream media bashing aspirin, as news is leaking out it may help in the battle against COVID.

According to a study by George Washington University (GWU), based in Washington D.C., aspirin may help alleviate some of the severest symptoms of COVID.

The Jerusalem Post reports that GWU’s study of 400 patients who had contracted COVID found that those who were regularly taking low doses of aspirin for issues unrelated to COVID had a much lower risk of severe COVID symptoms.

Low doses of aspirin is often recommended for those who dealing with heart issues and strokes.

The study found that those taking the readily available medication had:

• 47% lower death rate from COVID,
• 44% reduction in the use of ventilators, and
• 43% lower ICU admissions.

Speaking on behalf of the researchers, Dr. Jonathan Chow said, “As we learned about the connection between blood clots and COVID-19, we knew that aspirin – used to prevent stroke and heart attack – could be important for COVID-19 patients. Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death.”

READ: Aspirin lowers risk of COVID: New findings support preliminary Israeli trial

And this isn’t even the first research to suggest this.

A study conducted by Israeli researchers from Bar-Ilan University, Leumit Health Care Services, and Barzilai Medical Center found that those who were regularly taking lower doses of aspirin were also less likely to get COVID.

Their study of 10,000 people in Israel found that those regularly taking aspirin were 29% less likely to contract COVID, and if they did, recovered from the virus between two to three days faster than those who weren’t taking aspirin.

READ: Coronavirus: Aspirin may help prevent infection, Israeli study shows